Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials in progress
353 Safety and efficacy of tumor infiltrating lymphocytes (TIL, LN-145) in combination with pembrolizumab for advanced, recurrent or metastatic HNSCC
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 353 Safety and efficacy of tumor infiltrating lymphocytes (TIL, LN-145) in combination with pembrolizumab for advanced, recurrent or metastatic HNSCC